What's new

Orphan designation: florbetaben (18F) Diagnosis of ATTR amyloidosis, 22/05/2025 Positive

Orphan designation: florbetaben (18F) Diagnosis of ATTR amyloidosis, 22/05/2025 Positive

Jun 25, 2025 - 09:50
 0
Orphan designation: florbetaben (18F) Diagnosis of ATTR amyloidosis, 22/05/2025 Positive
Orphan designation: florbetaben (18F) Diagnosis of ATTR amyloidosis, 22/05/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: Tranilast Treatment of idiopathic pulmonary fibrosis, 22/05/...

Next Article

United Kingdom to Buy F-35A Lightning for Tactical Nuclear Strike Role

Related Posts

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 94, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 13, 2025  0

EMA roundtable with stakeholders on the 20th anniversary of the SME Regulation, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 October 2025, 09:30 (CEST) to 17 October 2025, 13:50 (CEST)

EMA roundtable with stakeholders on the 20th anniversar...

Jun 4, 2025  0

Human medicines European public assessment report (EPAR): Orencia, abatacept, Date of authorisation: 21/05/2007, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0